Abstract
Results of continuous sunitinib, in combination with cetuximab and irinotecan every other week (SIC) for compassionate use in heavily pre-treated patients with mCRC are presented.
Original language | English |
---|---|
Journal | Acta Oncologica |
Volume | 49 |
Issue number | 6 |
Pages (from-to) | 833-836 |
Number of pages | 4 |
ISSN | 0284-186X |
DOIs | |
Publication status | Published - 1. Aug 2010 |
Keywords
- Administration, Oral
- Adult
- Aged
- Antibodies, Monoclonal
- Antineoplastic Combined Chemotherapy Protocols
- Camptothecin
- Colorectal Neoplasms
- Denmark
- Drug Administration Schedule
- Female
- Humans
- Indoles
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Organoplatinum Compounds
- Pyrroles
- Receptor Protein-Tyrosine Kinases
- Retrospective Studies
- Treatment Outcome